Search

Your search keyword '"Jann, Johann‐Christoph"' showing total 217 results

Search Constraints

Start Over You searched for: Author "Jann, Johann‐Christoph" Remove constraint Author: "Jann, Johann‐Christoph"
217 results on '"Jann, Johann‐Christoph"'

Search Results

1. Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomes

3. Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms

4. Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell level

5. Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies

6. Functional analysis of structural variants in single cells using Strand-seq

7. Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes

8. Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes

9. Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states

10. Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at single cell level

11. Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)

13. Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics

16. Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium

17. Functional analysis of structural variants in single cells using Strand-seq

18. Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure

19. Functional analysis of structural variants in single cells using Strand-seq

21. Splicing Modulators Impair DNA Damage Response and Induce Killing of Cohesin-Mutant MDS/AML

22. Inhibition of Lysyl Oxidases Synergizes with 5-Azacytidine to Restore Erythropoiesis in Myeloid Neoplasms

23. ASXL1 Mutations Are Associated with a Response to the Combination of Alvocidib and 5-Azacytidine in Higher-Risk Myelodysplastic Syndromes

24. Abstract 6257: Mutations in the ASXL1 and ZRSR2 genes are associated with the response to the combination of alvocidib and 5-azacytidine in higher-risk myelodysplastic syndromes

25. Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNA

27. 3019 – SINGLE-CELL PROTEO-GENOMIC REFERENCE MAPS OF THE HEMATOPOIETIC SYSTEM ENABLE THE PURIFICATION AND MASSIVE PROFILING OF PRECISELY DEFINED CELL STATES

28. Haplotype-aware single-cell multiomics uncovers functional effects of somatic structural variation

29. Preclinical Assessment of Alvocidib in Combination with 5-Azacytidine in High-Risk Myelodysplastic Syndromes

30. Mesenchymal Stromal Cells (MSCs) from Myelodysplastic Syndromes (MDS) Are Not Clonally Mutated I n Vivo

31. Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes

33. Instructive Interaction between Myelodysplastic Hematopoiesis and the Bone Marrow Microenvironment at Single Cell Level

34. Subunit-Specific Analysis of Cohesin-Mutant Myeloid Malignancies Reveals Distinct Ontogeny and Outcomes

36. Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states

37. High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes

39. Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations

40. RNA-sequencing of acute promyelocytic leukemia primary blasts reveals novel molecular biomarkers of early death events

42. MutaSeq reveals the transcriptomic consequences of clonal evolution in acute myeloid leukemia

43. R-Loops-Induced ATR Signaling As a Potential Therapeutic Target in Myelodysplastic Syndrome

44. Comparison of Four Different Humanized Hematopoietic Niche Xenotransplantation Methods to Engraft Myelodysplastic Syndromes (MDS)

45. Deep sequencing of bone marrow microenvironments of patients with del(5q) myelodysplastic syndrome reveals imprints of antigenic selection as well as generation of novel T-cell clusters as a response pattern to lenalidomide

46. Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics

47. High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes.

48. Placebo Controlled Functional Analysis of Eltrombopag in a Preclinical Xenograft Model of Myelodysplastic Syndromes (MDS)

Catalog

Books, media, physical & digital resources